Search

Home > New FDA Approvals > 059 - FDA approves denosumab for SRE in MM; pivotal phase 3 trial for SP-102 in lumbar radicular pain/sciatica; FDA puts out 4 tips to quit smoking for consumers
Podcast: New FDA Approvals
Episode:

059 - FDA approves denosumab for SRE in MM; pivotal phase 3 trial for SP-102 in lumbar radicular pain/sciatica; FDA puts out 4 tips to quit smoking for consumers
Category: Science & Medicine
Duration: 00:10:39
Publish Date: 2018-01-08 07:00:00
Description:

January 8, 2018

1:18 FDA approves Xgeva (denosumab) for the prevention of skeletal-related events in patients with multiple myeloma http://www.amgen.com/media/news-releases/2018/01/fda-approves-xgeva-denosumab-for-the-prevention-of-skeletalrelated-events-in-patients-with-multiple-myeloma/

4:13 Semnur Pharmaceuticals begins pivotal phase 3 trial for SP-102 in patients with lumbar radicular pain/sciatica https://www.prnewswire.com/news-releases/semnur-pharmaceuticals-begins-pivotal-phase-3-trial-for-sp-102-in-patients-with-lumbar-radicular-painsciatica-300578706.html

6:51 FDA issues 4 tips to quit smoking

https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm590868.htm

 

Audible newfdaapprovals.com/audible

  6 Week Course “Everything you need to know to start your freelance medical writing business” starts January 15th, 2018 – info here: 6weekcourse.com
Total Play: 0